证券日报网讯 1月8日，创业慧康在互动平台回答投资者提问时表示，公司专注于医疗卫生健康信息化 的建设、研发及服务创新，产品涵盖智慧医疗、智慧卫生、医保、健康及养老等各种智慧场景。公司将 持续关注新兴医疗健康应用场景的市场机遇，若未来脑机接口等新应用场景在医疗行业逐步显现，公司 将依托现有技术积累与战略发展规划，及时跟进并积极探索拓展相关产品应用边界。 （编辑 丛可心） ...

有投资者在互动平台向创业慧康提问："公司是否储备脑机接口技术？" 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 针对上述提问，创业慧康回应称："尊敬的投资者，您好！公司专注于医疗卫生健康信息化的建设、研 发及服务创新，产品涵盖智慧医疗、智慧卫生、医保、健康及养老等各种智慧场景。公司将持续关注新 兴医疗健康应用场景的市场机遇，若未来脑机接口等新应用场景在医疗行业逐步显现，公司将依托现有 技术积累与战略发展规划，及时跟进并积极探索拓展相关产品应用边界。感谢您的关注！" ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 创业慧康回复：尊敬的投资者，您好！公司专注于医疗卫生健康信息化的建设、研发及服务创新，产品 涵盖智慧医疗、智慧卫生、医保、健康及养老等各种智慧场景。公司将持续关注新兴医疗健康应用场景 的市场机遇，若未来脑机接口等新应用场景在医疗行业逐步显现，公司将依托现有技术积累与战略发展 规划，及时跟进并积极探索拓展相关产品应用边界。感谢您的关注！ 证券之星消息，创业慧康(300451)01月08日在投资者关系平台上答复投资者关心的问题。 投资者提问：公司是否储备脑机接口技术？ ...

西南证券发布研报称，中国医疗人工智能行业空间较大，政策推动行业快速发展；讯飞医疗科技 (02506)具备自研基座大模型，性能上限持续抬升。星火医疗大模型X1能够显著降低幻觉现象，提升推 理的正确性、专业性与可解释性；基于大模型和大数据技术平台，构建多元化GBC客户产品矩阵。首 次覆盖，建议关注。 西南证券主要观点如下： 基于大模型和大数据技术平台，构建多元化GBC客户产品矩阵 截至2024年底，公司已向超过7万家基层医疗机构提供产品和服务，业务覆盖全国30多个省份、670多个 区县，以及500多家等级医院，其中包含了中国百强医院中的40多家和十强医院中的7家。1)To G基层医 疗服务业务25H1收入增速52.3%；区域管理平台解决方案25H1收入增速178.1%：基层医疗服务+区域管 理平台解决方案是基本盘，基层医疗服务业务线主要由智医助理和慢病管理组成，区域管理平台解决方 案主要是由智慧卫生和智慧医保组成；2)To B业务25H1收入下滑10%：主要由于大模型持续更新。业务 包括智慧医院+AI诊疗助理，提升医疗服务能力与效率；3)To C业务25H1收入增速10%：包括影像云平 台+诊后管理+讯飞晓医+智 ...

Core Viewpoint - The leading medical information technology company, Chuangye Huikang, is set to change ownership as Hangzhou Genghao Investment Management Partnership has initiated a share transfer process, marking a significant shift in control amidst declining performance for both companies [1][8]. Group 1: Ownership Change - Hangzhou Genghao has paid approximately 158 million yuan as the first installment for the share transfer [1]. - The agreement involves Hangzhou Genghao acquiring 9,652,509 shares from the largest shareholder, Ge Hang, representing 6.23% of the total share capital, at a price of 5.18 yuan per share, totaling 500 million yuan [3][4]. - Following the transfer, Hangzhou Genghao's voting rights will increase from 0% to 12.64%, making it the largest shareholder of Chuangye Huikang [4]. Group 2: Financial Performance - Chuangye Huikang has experienced three consecutive years of declining performance, with a reported net loss of 173 million yuan in 2024, marking its first loss since going public [9]. - For the first three quarters of 2025, the company reported a revenue of 862 million yuan, a decrease of 26.26% year-on-year, and a net loss of 122 million yuan, a staggering decline of 331.69% [10]. - Hangzhou Genghao's parent company, Huajian Medical, also reported a decline in performance, with a revenue of 1.27 billion yuan in the first half of 2025, down 6.2%, and a net profit of 38.32 million yuan, down 70% [7][8]. Group 3: Strategic Intent - The acquisition aims to position Chuangye Huikang as a leader in the AI healthcare sector, with plans for board restructuring and potential capital increases to enhance control [5][8]. - Chuangye Huikang, founded in 1997, focuses on medical information services and has seen its market value drop significantly from over 20 billion yuan at its peak [8][10].

Core Points - The company is planning a change in control, potentially moving from a state of no actual controller to having one, involving major shareholder Ge Hang and Hangzhou Genghao Zhito Management Consulting Partnership [1] - The company's stock will be suspended from trading starting November 10, 2025, for a period not exceeding two trading days [1] Company Overview - Founded in 1997, the company is one of the early entrants in the medical and health information technology sector in China, focusing on the construction, research, and service innovation of health information systems [1] - The company has implemented nearly 20,000 health information construction projects, serving over 7,000 industry users, with public health projects covering more than 370 districts and counties nationwide, accumulating approximately 300 million resident health records [1] Financial Performance - For the first half of 2025, the company reported total revenue of 577 million yuan, a year-on-year decrease of 20.65% [1] - The net loss attributable to shareholders for the same period was 80.55 million yuan, compared to a loss of 27.37 million yuan in the previous year, indicating an expanded loss [1] Industry Metrics - In the first half of 2025, the internet hospital prescription flow reached 190,000 orders, with a 140% increase in traditional Chinese medicine prescription collaborations [2] - The company has partnered with over 250 commercial insurance institutions and aggregated payment merchants totaling 2,000, with 48 million new transactions and a transaction volume of 8.5 billion yuan [2] - Cloud nursing collaborations involve over 250 institutions, with more than 7,600 nurses and 93,800 orders processed [2]

Group 1 - The stock price of Chuangyue Huikang closed at 5.96 yuan on August 5, 2025, with an increase of 0.34% compared to the previous trading day [1] - The company reported a trading volume of 60.64 million shares and a transaction amount of 361 million yuan, with a turnover rate of 3.97% [1] - Chuangyue Huikang, established in 1997 and listed in 2015, operates in the software development industry, focusing on smart healthcare, smart sanitation, medical insurance, health, and elderly care information solutions [1] Group 2 - In 2024, the company's revenue composition indicated that the medical sector accounted for 93.25%, while the non-medical sector made up 6.75% [1] - On the evening of August 5, the company announced that its second-largest shareholder, Philips, plans to reduce its holdings by up to 46.33 million shares, representing 3% of the total share capital, with a proposed reduction amounting to approximately 276 million yuan based on the closing price [1] - For the first quarter of 2025, the company reported a revenue of 290 million yuan, a year-on-year decrease of 22.67%, and a net loss of 15.64 million yuan [1] Group 3 - On August 5, the net inflow of main funds was 8.47 million yuan, with a cumulative net inflow of 22.62 million yuan over the past five days [2]